HNX:MED Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	367,081	443,136	402,741	401,051	343,951
Revenue Growth (YoY)	-17.16%	10.03%	0.42%	16.60%	-34.03%
Cost of Revenue	281,807	350,574	319,663	321,750	275,877
Gross Profit	85,274	92,561	83,078	79,301	68,074
Selling, General & Admin	64,155	70,368	68,897	70,666	59,184
Operating Expenses	64,155	70,368	68,897	70,666	59,184
Operating Income	21,119	22,193	14,181	8,634	8,890
Interest Expense	-2,218	-3,787	-5,394	-5,004	-3,619
Interest & Investment Income	490.9	790.11	6,580	5,811	4,790
Currency Exchange Gain (Loss)	-492.96	-690.35	-45.37	-	-
Other Non Operating Income (Expenses)	1,143	928.43	-212.84	-774.96	-4,533
EBT Excluding Unusual Items	20,043	19,434	15,109	8,666	5,528
Gain (Loss) on Sale of Investments	-92.74	-	-	-	-
Gain (Loss) on Sale of Assets	-	-16.21	-185.78	-	-
Pretax Income	19,950	19,418	14,923	8,666	5,528
Income Tax Expense	4,678	4,171	3,179	2,300	1,781
Net Income	15,272	15,247	11,744	6,366	3,747
Net Income to Common	15,272	15,247	11,744	6,366	3,747
Net Income Growth	0.16%	29.83%	84.49%	69.88%	-84.66%
Shares Outstanding (Basic)	12	12	12	9	6
Shares Outstanding (Diluted)	12	12	12	9	6
Shares Change (YoY)	-0.03%	-	32.18%	49.59%	-0.05%
EPS (Basic)	1231.00	1228.59	946.32	678.00	597.00
EPS (Diluted)	1231.00	1228.59	946.32	678.00	597.00
EPS Growth	0.20%	29.83%	39.58%	13.57%	-84.65%
Free Cash Flow	-20,153	37,674	-84,502	-91,039	7,746
Free Cash Flow Per Share	-1624.48	3035.74	-6809.19	-9696.32	1234.13
Dividend Per Share	-	-	900.000	500.000	250.000
Dividend Growth	-	-	80.00%	100.00%	-
Gross Margin	23.23%	20.89%	20.63%	19.77%	19.79%
Operating Margin	5.75%	5.01%	3.52%	2.15%	2.58%
Profit Margin	4.16%	3.44%	2.92%	1.59%	1.09%
Free Cash Flow Margin	-5.49%	8.50%	-20.98%	-22.70%	2.25%
EBITDA	28,434	30,109	22,625	18,654	18,426
EBITDA Margin	7.75%	6.79%	5.62%	4.65%	5.36%
D&A For EBITDA	7,314	7,916	8,444	10,020	9,536
EBIT	21,119	22,193	14,181	8,634	8,890
EBIT Margin	5.75%	5.01%	3.52%	2.15%	2.58%
Effective Tax Rate	23.45%	21.48%	21.30%	26.55%	32.22%
Revenue as Reported	367,081	443,136	402,741	401,051	343,951

Source: S&P Global Market Intelligence. Standard template. Financial Sources.